当前位置： SCI文献检索 > Frontiers in Cellular and Infection Microbiology期刊下所有文献 > Nanocarriers From Natural Lipids With In Vitro Activity Against Campylobacter jejuni.

Nanocarriers From Natural Lipids With In Vitro Activity Against Campylobacter jejuni.

Abstract：

:Campylobacter jejuni (CJ) is the most prevalent zoonotic pathogen of chicken meat and related products, which may lead to gastroenteritis and autoimmune diseases in humans. Although controlling this bacterium is important, CJ strains resistance against traditional antibiotic therapy has been increased. Vegetable oils and fats are natural biomaterials explored since the Ancient times, due to their therapeutic properties. Nanotechnology has promoted the miniaturization of materials, improving bioavailability and efficacy, while reducing the toxicity of loaded active molecules. In this work, a screening of 28 vegetable oils was firstly performed, in order to select anti-CJ candidates by the disc diffusion test. Thus, the selected liquid lipids were used as active molecules in nanostructured lipid carriers (NLC) formulations. The three resultant systems were characterized in terms of particle size (~200 nm), polydispersity index (~0.15), and zeta potential (~-35mV), and its physicochemical stability was confirmed for a year, at 25°C. The structural properties of NLC were assessed by infrared (FTIR-ATR) and differential scanning calorimetry (DSC) analyses. The spherical nanoparticle morphology and narrow size distribution was observed by transmission electron microscopy (TEM) and field emission scanning electron (FE-SEM) analyses, respectively. Then, the in vitro antimicrobial activity test determined the minimum inhibitory concentration (MIC) of each formulation against CJ strains, in both free (1-3 mg/ml-1) and sessile (0.78 mg/ml-1) forms. Finally, the in vitro biocompatibility of NLC was demonstrated through cell viability using VERO cell line, in which F6 was found twice less cytotoxic than pure olibanum oil. Considering the abovementioned achieved, F6 formulation is able to be evaluated in the in vivo anti-CJ efficacy assays.

journal_name

Front Cell Infect Microbiol

journal_title

Frontiers in cellular and infection microbiology

authors

Ribeiro LNM,de Paula E,Rossi DA,Martins FA,de Melo RT,Monteiro GP,Breitkreitz MC,Goulart LR,Fonseca BB

doi

10.3389/fcimb.2020.571040

subject

Has Abstract

pub_date

2021-01-08 00:00:00

pages

571040

issn

2235-2988

journal_volume

pub_type

杂志文章

在线工具

Nanocarriers From Natural Lipids With In Vitro Activity Against Campylobacter jejuni.